← Back to Search

Impact of an Open Lung Extubation Strategy on Postoperative Pulmonary Complications

N/A
Waitlist Available
Led By Martin Girard, MD, FRCPC
Research Sponsored by Centre hospitalier de l'Université de Montréal (CHUM)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at the end of the surgery

Summary

Perioperative respiratory complications are a major source of morbidity and mortality. Postoperative atelectasis plays a central role in their development. Protective "open lung" mechanical ventilation aims to minimize the occurrence of atelectasis during the perioperative period. Randomized controlled studies have been performed comparing various "open lung" ventilation protocols, but these studies report varying and conflicting effects. The interpretation of these studies is complicated by the absence of imagery supporting the pulmonary impact associated with the use of different ventilation strategies. Imaging studies suggest that the gain in pulmonary gas content in "open lung" ventilation regimens disappears within minutes after the extubation. Thus, the potential benefits of open-lung ventilation appear to be lost if, at the time of extubation, no measures are used to keep the lungs well aerated. Recent expert recommendations on good mechanical ventilation practices in the operating room conclude that there is actually no quality study on extubation. Extubation is a very common practice for anesthesiologists as part of their daily clinical practice. It is therefore imperative to generate evidence on good clinical practice during anesthetic emergence in order to potentially identify an effective extubation strategy to reduce postoperative pulmonary complications.

Eligible Conditions
  • Collapsed Lung
  • Pulmonary Atelectasis
  • Anesthesia Complication
  • Anesthesia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~15 minutes after the patient enters the recovery room
This trial's timeline: 3 weeks for screening, Varies for treatment, and 15 minutes after the patient enters the recovery room for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Protocol adherence rate
Other study objectives
Comparison of pulmonary aeration using the qLUS score in the two intervention groups
Estimated baseline rates of postoperative respiratory complications in the two intervention groups

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Emergence from general anesthesia with an open lung extubation strategyActive Control1 Intervention
Group II: Emergence from general anesthesia with a conventional extubation strategyPlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

Centre hospitalier de l'Université de Montréal (CHUM)Lead Sponsor
380 Previous Clinical Trials
131,520 Total Patients Enrolled
Martin Girard, MD, FRCPCPrincipal InvestigatorCentre hospitalier de l'Université de Montréal (CHUM)
7 Previous Clinical Trials
275 Total Patients Enrolled
~17 spots leftby Jan 2026